bupropion SR
Selected indexed studies
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). (Obesity (Silver Spring), 2013) [PMID:23408728]
- Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR. (Drugs R D, 2010) [PMID:20509712]
- The Black Book of Psychotropic Dosing and Monitoring. (Psychopharmacol Bull, 2024) [PMID:38993656]
_Worker-drafted node — pending editorial review._
Connections
bupropion SR is a side effect of
Sources
- The Black Book of Psychotropic Dosing and Monitoring. (2024) pubmed
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). (2013) pubmed
- Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR. (2010) pubmed
- Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity. (2016) pubmed
- Combination bupropion SR and varenicline for smoking cessation: a systematic review. (2016) pubmed
- Bupropion SR for smoking cessation. (2003) pubmed
- Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. (2022) pubmed
- The use of bupropion SR in cigarette smoking cessation. (2008) pubmed
- Obesity Pharmacotherapy. (2018) pubmed
- Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'? (2011) pubmed